Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer



Status:Recruiting
Conditions:Prostate Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:9/8/2018
Start Date:August 1, 2017
End Date:December 2019
Contact:Simon P Kim, MD, MPH
Email:Simon.Kim@uhhospitals.org
Phone:216-844-3009

Use our guide to learn which trials are right for you!

Development and Testing of a Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer

A pilot study testing the effect of an in-visit English and Spanish language decision aid for
Hispanic-Latino men using best practices of cultural tailoring to be used in urology
practice. Subjects will be followed for approximately 1 year during standard care in-clinic
office visits. Study results and subject surveys will be analyzed to determine clinical
utility of the tool.

The objective of this research is to determine the effect of a culturally tailored decision
aid tool on the cancer treatment decisions of Hispanic-Latino patients.

The specific aims are:

i. To develop and pilot test in an uncontrolled fashion an in-visit English and Spanish
language decision aid for Hispanic-Latino men using best practices of cultural tailoring to
be used in urology practice ii. To pilot and test the impact of a culturally tailored,
English and Spanish language version of the Prostate Choice in-visit decision aid on decision
quality, knowledge, and quality of life in low-income Hispanic/Latino patients diagnosed with
localized prostate cancer iii. To assess the barriers and facilitators of decision aid use
including the relative contribution of language-concordance on 1-year practice implementation
parameters.

Inclusion Criteria:

- Subjects utilize English or Spanish as their primary spoken or written language and
identify with a Latino ethnicity and/or culture

- Men with a new histologic diagnosis of localized prostate cancer

- PSA level of 0.1 - 50 ng/dl

- Gleason score of 6 - 10

- Cancer stage: T1 - 4N x M0

Exclusion Criteria:

- Metastatic disease, including lymph nodes or distant metastasis

- PSA > 50 ng/dl

- Individuals with a medical condition that necessitates a specific prostate cancer
treatment plan

- Individuals that are unwilling or unable to attend study visits or are planning to
move out of a study site coverage area during the subject's anticipated participation
in the study
We found this trial at
4
sites
Galveston, Texas
Phone: 409-772-2091
1400
mi
from 91732
Galveston, TX
Click here to add this to my saved trials
1969 W Ogden Ave
Chicago, Illinois 60612
(312) 864-6000
Phone: 312-864-0913
John H. Stroger, Jr. Hospital of Cook County The Level 1 Trauma Center is one...
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
2500 Metrohealth Dr
Cleveland, Ohio 44109
(216) 778-7800
Phone: 216-778-4391
MetroHealth Med Ctr The MetroHealth System is one of the largest, most comprehensive health care...
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials